As a positive control for CRISPR competency, targeting of proliferating cell nuclear antigen (PCNA) by sgPCNA reduced the viability of the individual cancer cell lines included in this study (Supplemental Figure 2L), ruling out the possibility of incomparable genome editing efficiency. Here, PCNA is linked to cancer.